These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4345101)

  • 21. The effect of pH on tachyphylaxis to angiotensin peptides in the isolated guinea pig ileum and rat uterus.
    Paiva TB; Juliano L; Nouailhetas VL; Paiva AC
    Eur J Pharmacol; 1974 Feb; 25(2):191-6. PubMed ID: 4373250
    [No Abstract]   [Full Text] [Related]  

  • 22. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
    Karpitskiĭ VV; Gomazkov OA
    Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206
    [No Abstract]   [Full Text] [Related]  

  • 23. A new class of angiotensin inhibitors: N-methylphenylalanine analogs.
    Peña C; Stewart JM; Goodfriend TC
    Life Sci; 1974 Apr; 14(7):1331-6. PubMed ID: 4363010
    [No Abstract]   [Full Text] [Related]  

  • 24. A specific competitive inhibitor of angiotensin II.
    Marshall GR; Vine W; Needlemann P
    Proc Natl Acad Sci U S A; 1970 Nov; 67(3):1624-30. PubMed ID: 4322025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 26. Irreversible inhibition of angiotensin II activity on the rat uterus by an alkylating angiotensin derivative.
    Paiva TB; Miyamoto ME; Paiva AC
    Pharmacology; 1974; 12(3):186-91. PubMed ID: 4374707
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of the adrenal gland on the pressor effect and antagonistic potency of angiotensin II analogs.
    Muñoz-Ramírez H; Khosla MC; Bumpus FM; Khairallah PA
    Eur J Pharmacol; 1975 Mar; 31(1):122-35. PubMed ID: 236194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new, long-lasting competitive inhibitor of angiotensin.
    Türker RK; Hall MM; Yamamoto M; Sweet CS; Bumpus FM
    Science; 1972 Sep; 177(4055):1203-5. PubMed ID: 4341570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
    O'Connor GJ; Baranowski RL; Kurtzman NA
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for angiotensin-induced hypertension.
    Lancet; 1971 Feb; 1(7693):277-8. PubMed ID: 4100023
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.
    Collier JG; Robinson BF; Vane JR
    Lancet; 1973 Jan; 1(7794):72-4. PubMed ID: 4118651
    [No Abstract]   [Full Text] [Related]  

  • 32. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA; Cahn WY; Du Vigneaud V
    J Med Chem; 1972 Jan; 15(1):11-2. PubMed ID: 5061981
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of pregnancy on the angiotensin II pressor response in the rabbit.
    Berssenbrugge AD; Goodfriend TL; Ball DL; Rankin JH
    Am J Obstet Gynecol; 1980 Mar; 136(6):762-7. PubMed ID: 7355962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Synthetic angiotensin inhibiting peptides.
    Paiva AC
    Acta Physiol Lat Am; 1973; 23(6):530-2. PubMed ID: 4369064
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of [1-Isoleucine-, 3-proline-, and 5-alanine]-angiotensins. II.
    Khosla MC; Chaturvedi NC; Smeby RR; Bumpus FM
    Biochemistry; 1968 Oct; 7(10):3417-21. PubMed ID: 4386645
    [No Abstract]   [Full Text] [Related]  

  • 36. Vascular permeability factor: dissociation from the angiotensin II induced pressor and drinking responses.
    Vaughan ED; Gavras H; Laragh JH; Koss MN
    Nature; 1973 Mar; 242(5396):334-5. PubMed ID: 4349236
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis of analogs of (8-isoleucine)angiotensin II with variations in position 1.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Apr; 17(4):431-3. PubMed ID: 4364509
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.
    Engel SL; Schaeffer TR; Gold BI; Rubin B
    Proc Soc Exp Biol Med; 1972 May; 140(1):240-4. PubMed ID: 4338183
    [No Abstract]   [Full Text] [Related]  

  • 39. Antagonists of angiotensin. Substitution of an aliphatic chain to phenyl ring in position 8.
    Regoli D; Park WK; Rioux F; Chan CS
    Rev Can Biol; 1971 Dec; 30(4):319-29. PubMed ID: 4332582
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors that influence the antagonistic properties of angiotensin II antagonists.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1973 Jul; 16(7):829-32. PubMed ID: 4353602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.